BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29
• 30

• Business

  NeurogesX, Inc. Reports Third Quarter 2007 Financial Results

  November 15, 2007

   · 

  7 min read
• Drug Development

  The New England Journal of Medicine Study Shows Bristol-Myers Squibb and ImClone Systems Incorporated’s ERBITUX(R) Improves Survival in Advanced Colorectal Cancer

  November 15, 2007

   · 

  11 min read
• Drug Development

  BiPar Sciences, Inc. Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data

  November 15, 2007

   · 

  4 min read
• Drug Development

  Genta Incorporated Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases Safety Analysis Shows Good Tolerance with No Serious Adverse Reactions

  November 15, 2007

   · 

  5 min read
• Business

  BioMS Medical Announces Third Quarter 2007 Results

  November 15, 2007

   · 

  4 min read
• FDA

  Schering-Plough Corporation PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients

  November 15, 2007

   · 

  11 min read
• Royal Philips Electronics N.V. and Elsevier, Inc. Integrate Speech Recognition and Radiology Diagnostic Reference System

  November 15, 2007

   · 

  3 min read
• Policy

  Carrington Laboratories, Inc. Reports on ISO 9001:2000 Inspection

  November 15, 2007

   · 

  2 min read
• Business

  Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008

  November 15, 2007

   · 

  7 min read
• Policy

  Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration

  November 15, 2007

   · 

  6 min read